Serum Lipid Hydroperoxide Levels and Paraoxonase Activity in Patients With Lung, Breast, and Colorectal Cancer

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 3, 2012, Pages 155-160

  Balci, H ^a   Genc, H ^b   Papila, C ^a   Can, G ^a   Papila, B ^a   Yanardag, H ^a   Uzun, H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Arylesterase; Cancer; Lipid hydroperoxide; Paraoxonase 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; LIPID HYDROPEROXIDE;

ADULT; AGED; ARTICLE; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARYLDIALKYLPHOSPHATASE; BREAST NEOPLASMS; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIPID PEROXIDES; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 84861473973     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21503     Document Type: Article

References (38)

1. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998;39:1529-1542.
2. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res 2004;95:764-772.
3. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative disease of aging. Proc Natl Acad Sci 1993;90:7915-7922.
4. Rochu D, Chabrière E, Masson P. Human paraoxonase: A promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 2007;233:47-59.
5. Costa LG, Cole TB, Vitalone A, Furlong CE. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clinica Chimica Acta 2005;352:37-47.
6. Aldridge WN. Serum esterases. II. An enzyme hydrolysing diethyl pnitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem J 95;53:117-124.
7. Aldridge WN. Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination. Biochem J 1953;53:110-117.
8. Deakin SP, James RW. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci 2004;107:435-447.
9. Arab K, Steghens JP. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 2004;325:158-163.
10. Marnett LJ. Oxyradicals and DNAdamage. Carcinogenesis 2000;21:361-370.
11. Brash AR. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999;274:23679-23682.
12. Lee SH, Williams MV, Dubois RN, Blair IA. Cyclooxygenase-2-mediated DNA damage. J Biol Chem 2005;280:28337-28346.
13. Tanaka T. Effect of diet on human carcinogenesis. Crit Rev Oncol Hematol 1997;25:73-95.
14. Tanaka, K, Kawabata, K, Kakumoto, M. Citrus auraptene exerts dose dependent chemopreventive activity in rat large bowel tumorigenesis: The inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of Phase IIdrug metabolizing enzymes. Cancer Res 1998;58:2550-2556.
15. Manoj GR, Thampi BSH, Menon VP, Leelamma, S. Influence of dietary fibre from coconut kernel (Cocus nucifera) on the 1, 2-dimethylhydrazine-induced lipid peroxidation in rats. J Nutr Biochem 1999;10:555-560.
16. Cheeseman KH, Collins M, Proudfoot K, et al. Studies on lipid peroxidation in normal and tumor tissues. The Novikoff rat liver tumor. Biochem J 1986;235:507-514.
17. Costa LG, Giordano G, Furlong CE. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem Pharmacol 2011;81:337-344.
18. Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992;30:391-395.
19. Cakatay U, Kayali R, Uzun H. Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population. Clin Exp Med 2008;8:51-57.
20. Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999;300:58-62.
21. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998;39:1529-1542.
22. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003;31:1441-1444.
23. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993;3:73-76.
24. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996;14:334-336.
25. Shih DM, Gu L, Xia YR, et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998;394:284-287.
26. Serhatlioglu S, Gursu MF, Gulcu F, Canatan H, Godekmerdan A. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Cell Biochem Funct 2003;21:371-375.
27. Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 2007;7:48--55.
28. Kaynar H, Meral M, Turhan H, Keles M, Celik G, Akcay F. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett 2005;227:133-139.
29. Blau S, Rubinstein A, Bass P, Singaram C, Kohen R. Differences in the reducing power along the rat GI tract: Lower antioxidant capacity of the colon. Molec Cell Biochem 1999;194:185-191.
30. Di Giacomo C, Acquaviva R, Lanteri R, Licata F, Licata A, Vanella A. Nonproteic antioxidant status in plasma of subjects with colon cancer. Exp Biol Med (Maywood) 2003;228:525-528.
31. Gönenç A, Erten D, Aslan S, Akinci M, Simşek B, Torun M. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int 2006;30:376-380.
32. Yeh CC, Hou MF, Tsai SM, et al. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta 2005;361:104-111.
33. Sener DE, Gönenç A, Akinci M, Torun M. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct 2007;25:377-382.
34. Camuzcuoglu H, Arioz DT, Toy H, Kurt S, Celik H, Erel O. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol Oncol 2009;112:481-485.
35. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69:541-550.
36. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997;11:457-465.
37. Chait A, Han CY, Oram JF, Heinecke JW. Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: Markers or mediators of cardiovascular disease? J Lipid Res 2005;46:389-403.
38. Samra ZQ, Pervaiz S, Shaheen S, Dar N, Athar MA. Determination of oxygen derived free radicals producer (xanthine oxidase) and scavenger (paraoxonase1) enzymes and lipid parameters in different cancer patients. Clin Lab 2011;57:741-747.